Sam Brusco, Associate Editor04.06.22
Cardinal Health is collaborating with Innara Health, a company focused on feeding development for prematurely born newborns and infants, to redesign Innara’s NTrainer system redesign. The companies aim to make the next-gen NTrainer smaller, more intuitive, and easier to integrate with NICU protocols.
“We are thrilled to have a globally recognized organization like Cardinal Health support Innara and the NTrainer. Not only is this collaboration validating for our clients and our team, but it is also a clear indication of Cardinal Health’s commitment to improving clinical outcomes through innovation. We look forward to seeing their contributions toward providing preterm infants with their best opportunity to develop, grow, and thrive,” Innara Health CEO Chris Mathia told the press.
The U.S. Food and Drug Administration (FDA)-cleared NTrainer focuses on the critical pre-feeding skill of non-nutritive suck (NNS) for newborns and preterm infants. Preterm infants often lack or have weak NNS but it’s needed to transition from feeding tubes to the breast or bottle.
Innara’s tech can improve NNS proficiency and NTrainer has been clinically proven to boost feeding outcomes and decrease length of NICU stay.
“Cardinal Health is dedicated to improving patient outcomes and we’re looking forward to supporting Innara’s critical work,” said Kelley Moffett, Cardinal Health’s senior VP of Global Products. “We see tremendous value in this relationship, given our shared focus on neonatal nutrition, and we’re proud to support development and commercialization of the next generation NTrainer.”
Innara won a top award of $50,000 in FDA funding in MedTech Innovator’s 2020 “Make Your Medical Device Pitch for Kids!” competition.
“We are thrilled to have a globally recognized organization like Cardinal Health support Innara and the NTrainer. Not only is this collaboration validating for our clients and our team, but it is also a clear indication of Cardinal Health’s commitment to improving clinical outcomes through innovation. We look forward to seeing their contributions toward providing preterm infants with their best opportunity to develop, grow, and thrive,” Innara Health CEO Chris Mathia told the press.
The U.S. Food and Drug Administration (FDA)-cleared NTrainer focuses on the critical pre-feeding skill of non-nutritive suck (NNS) for newborns and preterm infants. Preterm infants often lack or have weak NNS but it’s needed to transition from feeding tubes to the breast or bottle.
Innara’s tech can improve NNS proficiency and NTrainer has been clinically proven to boost feeding outcomes and decrease length of NICU stay.
“Cardinal Health is dedicated to improving patient outcomes and we’re looking forward to supporting Innara’s critical work,” said Kelley Moffett, Cardinal Health’s senior VP of Global Products. “We see tremendous value in this relationship, given our shared focus on neonatal nutrition, and we’re proud to support development and commercialization of the next generation NTrainer.”
Innara won a top award of $50,000 in FDA funding in MedTech Innovator’s 2020 “Make Your Medical Device Pitch for Kids!” competition.